August 07, 2025 16:30 ET | Source: Annexon Biosciences New Pilot Appoints Designated Product Development Coordinator to Navigate Regulatory Interactions,…
MARKHAM, Ontario, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today reported results for…
FORT LAUDERDALE, Fla., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Cannabis isn’t just transforming laws and lifestyles but also transforming America’s…
August 06, 2025 16:45 ET | Source: Neuronetics MALVERN, Pa., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM),…
August 05, 2025 20:17 ET | Source: BriaCell Therapeutics Corp. PHILADELPHIA and VANCOUVER, British Columbia, Aug. 05, 2025 (GLOBE NEWSWIRE)…
Pipeline led by a new proprietary oral small molecule GLP-1 agonist and six additional innovative programs targeting the GIP, Amylin…
HOUSTON and SINGAPORE, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Respiree, a health tech company developing artificial intelligence (AI) platforms to…
Recent lab results proved the Company’s hypothesis that disguising cancer cells to look like common infectious diseases can trick immune…
Has more than 30 years of experience bringing innovations to market, including one of the world’s first drug-eluting coronary stents…
First patient in Phase I/II clinical trial expected to be enrolled in Q4 2025UK Clinical Trial Application (CTA) approval shortly…